Rasalam, Roy, Atherton, John J., Deed, Gary, Molloy-Bland, Michael, Cohen, Neale, and Sindone, Andrew (2021) Sodium-glucose cotransporter 2 inhibitor effects on heart failure hospitalization and cardiac function: systematic review. ESC Heart Failure, 8 (5). pp. 4093-4118.

Sindone, A., Atherton, J., Deed, G., Molloy-Bland, M., Cohen, N., and Rasalam, R. (2021) Systematic review of the effects of sodium-glucose cotransporter 2 inhibitors on hospitalisation for heart failure and cardiac structure or function, and exploratory assessment of potential mechanisms. Heart, Lung and Circulation, 30 (Supplement 3). 101. S136-S137.

Rasalam, Roy, Atherton, John J., Deed, Gary, Molloy-Bland, Michael, Cohen, Neale, and Sindone, Andrew (2021) Systematic review of the effects of sodium-glucose cotransporter 2 inhibitors on hospitalization for heart failure and cardiac structure or function, and exploratory assessment of potential mechanisms. In: [Presented at the Australasian Diabetes Congress 2021]. From: Australasian Diabetes Congress 2021 (ADS/ADEA Annual Scientific Meeting), 11-13 August 2021, Online.

O'Neil, Adrienne, Taylor, Barr, Sanderson, Kristy, Cyril, Sheila, Chan, Bianca, Hawkes, Anna L., Hare, David L., Jelinek, Michael, Venugopal, Kamalesh, Atherton, John J., Amerena, John, Grigg, Leeanne, Walters, Darren L., and Oldenburg, Brian (2014) Efficacy and feasibility of a tele-health intervention for acute coronary syndrome patients with depression: results of the "MoodCare" randomized controlled trial. Annals of Behavioral Medicine, 48 (2). pp. 163-174.

Hawkes, Anna L., Atherton, John, Taylor, C. Barr, Scuffham, Paul, Eadie, Kathy, Houston Miller, Nancy , and Oldenburg, Brian (2009) Randomised controlled trial of a secondary prevention program for myocardial infarction patients ('ProActive Heart'): study protocol. Secondary prevention program for myocardial infarction patients. BMC Cardiovascular Disorders, 9 (16). - .